M&A Deal Summary

Abbott Acquires Solvay Pharmaceuticals

On February 15, 2010, Abbott acquired life science company Solvay Pharmaceuticals from Solvay for 6.1B USD

Acquisition Highlights
  • This is Abbott’s 7th transaction in the Life Science sector.
  • This is Abbott’s 4th largest (disclosed) transaction.
  • This is Abbott’s 1st transaction in Belgium.

M&A Deal Summary

Date 2010-02-15
Target Solvay Pharmaceuticals
Sector Life Science
Buyer(s) Abbott
Sellers(s) Solvay
Deal Type Add-on Acquisition
Deal Value 6.1B USD

Target

Solvay Pharmaceuticals

Brussels, Belgium
Solvay Pharmaceuticals is a provider of generic drugs and other pharmaceutical products.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abbott

North Chicago, Illinois, United States

Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.


DEAL STATS #
Overall 19 of 36
Sector: Life Science M&A 7 of 12
Type: Add-on Acquisition M&A Deals 19 of 36
Country: Belgium M&A 1 of 1
Year: 2010 M&A 1 of 4
Size (of disclosed) 4 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-18 STARLIMS Technologies

Hollywood, Florida, United States

STARLIMS Technologies is a provider of laboratory information management systems. STARLIMS Technologies was founded in 1986 and is based in Hollywood, Florida.

Buy $123M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-09 Facet Biotech

Redwood City, California, United States

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of five clinical-stage products focused in multiple sclerosis and oncology, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics.

Buy $450M

Seller(S) 1

SELLER

Solvay

Brussels, Belgium

Category Company
Founded 1863
Sector Chemicals
Employees9,000
Revenue 5.1B EUR (2024)
DESCRIPTION

Solvay is a chemical company that harnesses the power of chemistry to create innovative, sustainable solutions that answer essential needs such as purifying the air and water, preserving food supplies, protecting health and well-being, creating eco-friendly clothing, making the tires of cars more sustainable, and cleaning and protecting our homes. Solvay was founded in 1863 and is based in Brussels, Belgium.


DEAL STATS #
Overall 1 of 10
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Belgium M&A 1 of 3
Year: 2010 M&A 1 of 1
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-06-14 Unimed Pharmaceuticals

Buffalo Grove, Illinois, United States

Unimed Pharmaceuticals LLC is a manufacturer of drugs.

Buy $123M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-08-24 The Rhodia Group

Courbevoie, France

The Rhodia Group is a manufacturer of specialty chemicals.

Buy €3.4B